Cargando…

Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease

Parkinson’s disease (PD) is characterized by cerebral dopamine depletion that causes motor and cognitive deficits. The dopamine-related gene ANKK1 has been associated with neuropsychiatric disorders with a dopaminergic deficiency in the striatum. This study aims to define the contribution of ANKK1 r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Santamarina, Estela, García-Ruiz, Pedro, Martínez-Rubio, Dolores, Ezquerra, Mario, Pla-Navarro, Irene, Puente, Jorge, Martí, María José, Palau, Francesc, Hoenicka, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110570/ https://www.ncbi.nlm.nih.gov/pubmed/33972609 http://dx.doi.org/10.1038/s41598-021-89300-6

Ejemplares similares

Author Correction: Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease
por: Pérez‑Santamarina, Estela, et al.
Publicado: (2022)

ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism
por: Rubio-Solsona, Estrella, et al.
Publicado: (2018)

Correction: ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism
por: Rubio-Solsona, Estrella, et al.
Publicado: (2018)

The ANKK1/DRD2 locus is a genomic substrate for affective priming and recognition of angry faces
por: Koeneke, Alejandra, et al.
Publicado: (2015)

Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish
por: Leggieri, Adele, et al.
Publicado: (2022)

Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites
por: Cantarero, Lara, et al.
Publicado: (2023)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Analysis of Selected Variants of DRD2 and ANKK1 Genes in Combat Athletes
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2021)

Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia
por: Nkam, Irene, et al.
Publicado: (2017)

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015)

Association between ANKK1 (rs1800497) and LTA (rs909253) Genetic Variants and Risk of Schizophrenia
por: Arab, Arwa H., et al.
Publicado: (2015)

Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor
por: White, Melanie J, et al.
Publicado: (2008)

Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia
por: Michalczyk, Anna, et al.
Publicado: (2020)

Temporomandibular disorder in construction workers associated with ANKK1 and DRD2 genes
por: Baratto, Samantha Schaffer Pugsley, et al.
Publicado: (2022)

Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia
por: Pinto, Jeizziani Aparecida Ferreira, et al.
Publicado: (2018)

A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response
por: Macare, Christine, et al.
Publicado: (2018)

ANKK1 and TH gene variants in combination with paternal maltreatment increase susceptibility to both cognitive and attentive impulsivity
por: Palumbo, Sara, et al.
Publicado: (2022)

COMT and ANKK1-Taq-Ia Genetic Polymorphisms Influence Visual Working Memory
por: Berryhill, Marian E., et al.
Publicado: (2013)

Mitochondria–lysosome membrane contacts are defective in GDAP1-related Charcot–Marie–Tooth disease
por: Cantarero, Lara, et al.
Publicado: (2020)

Parkinson’s disease as a systemic pathology
por: Ezquerra, Mario, et al.
Publicado: (2019)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Associations of Prenatal Nicotine Exposure and the Dopamine Related Genes ANKK1 and DRD2 to Verbal Language
por: Eicher, John D., et al.
Publicado: (2013)

Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid
por: Li, Hongliang, et al.
Publicado: (2015)

Non-Motor Symptoms in PLA2G6-Associated Dystonia-Parkinsonism: A Case Report and Literature Review
por: Vela-Desojo, Lydia, et al.
Publicado: (2022)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Athletic performance, sports experience, and exercise addiction: an association study on ANKK1 gene polymorphism rs1800497
por: Bayraktar, Isık, et al.
Publicado: (2023)

Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants
por: Natera‐de Benito, Daniel, et al.
Publicado: (2023)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Decoding Neuromuscular Disorders Using Phenotypic Clusters Obtained From Co-Occurrence Networks
por: Díaz-Santiago, Elena, et al.
Publicado: (2021)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
por: Costa, Alberto, et al.
Publicado: (2008)

Dopaminergic modulation of the praxis network in Parkinson's disease
por: Matt, Eva, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v4b1g00k8pi8tj7ecb6m94mq1d